4th Quarter - Report

SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC

Firm
Client
Income
—
Expenses
$230,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Committee on Foreign Investment in the United States (CFIUS) reform

LobbyistCovered position, as disclosed
MARGARET MANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Orphan drug tax credit

LobbyistCovered position, as disclosed
MARGARET MANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

HR 5340/S1390: Stronger Patents Act

LobbyistCovered position, as disclosed
MARGARET MANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5340 (115th)

Health Issues HCR

HR 2587/S1194: Medical Nutrition Equity Act of 2017 HR6: Support for Patients and Communities Act 340B Drug Discount Program Orphan Drug Act Gene Therapy Drug Pricing

LobbyistCovered position, as disclosed
MARGARET MANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2587 (115th), H.R. 6 (115th)

Medicare/Medicaid MMM

- Home Infusion technical change to H.R.6 21st Century Cures to move wrap around training and monitoring services benefit forward from 2021 to 2018 implementation. - Medicare coverage and reimbursement - Medicare Part B drug payment model demonstration - HR 4724: Medicare IVIG Access Enhancement Act - Medicare Part D

LobbyistCovered position, as disclosed
MARGARET MANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (115th), H.R. 4724 (115th)

Pharmacy PHA

-Medicaid rare disease patient access to therapy Patient access to therapy, including Medicaid, Medicare, and insurance. -Orphan Drug Act regulations -Expanded Access -Rare Disease awareness -Newborn Screening

LobbyistCovered position, as disclosed
MARGARET MANN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.